Publications:

RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer.

Molecular Oncology

van Helden, Erik J EJ; Angus, Lindsay L; Menke-van der Houven van Oordt, C Willemien CW; Heideman, Daniëlle A M DAM; Boon, Eline E; van Es, Suzanne C SC; Radema, Sandra A SA; van Herpen, Carla M L CML; de Groot, Derk Jan A DJA; de Vries, Elisabeth G E EGE; Jansen, Maurice P H M MPHM; Sleijfer, Stefan S; Verheul, Henk M W HMW

Publication Date: 2019-11

Variant appearance in text: KRAS: S89P

PubMed Link: 31350822

Variant Present in the following documents:

• Main text
• MOL2-13-2361-s006.xlsx, sheet 1
• MOL2-13-2361.pdf
• MOL2-13-2361-s007.xlsx, sheet 1

View BVdb publication page